- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metastatic Solid Tumor in New Zealand
Total 4668 results
-
St Vincent's Hospital, SydneyTerminatedSolid Tumor | Androgen Receptor Gene OverexpressionAustralia
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Roswell Park Cancer InstituteCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Tufts Medical CenterTerminatedBrain Cancer | Choroid Plexus TumorsUnited States, Hungary, New Zealand, Germany
-
Eisai Inc.Completed
-
Chugai PharmaceuticalCompletedSolid TumorsUnited States, France, Netherlands
-
Daiichi Sankyo, Inc.Medpace, Inc.CompletedCancer | Solid Tumor | Hepatic ImpairmentUnited States
-
MedImmune LLCCompletedCancer | Solid TumorsUnited States, Spain
-
Synta Pharmaceuticals Corp.CompletedLymphoma | Leukemia | Hematological Malignancies | Metastatic or Unresectable Solid TumorsUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | NeuroblastomaUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Milton S. Hershey Medical Center; Stanford University and other collaboratorsActive, not recruitingLymphoma | Leukemia | Solid Tumor | Central Nervous System TumorUnited States, Canada
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Taiwan, China, Korea, Republic of, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Hoffmann-La RocheRecruitingAdvanced Solid TumorsUnited States
-
Incyte CorporationTerminatedSolid TumorsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Alnylam PharmaceuticalsCompleted
-
Y-mAbs TherapeuticsWithdrawnSolid Tumor, Adult | Leptomeningeal MetastasisUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterStanford University; Juno Therapeutics, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterUniversity of Wisconsin, Madison; Duke University; AEterna ZentarisCompleted
-
DualityBio Inc.BioNTech SERecruitingAdvanced Solid TumorUnited States, China, Puerto Rico
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Netherlands, Italy
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Korea, Republic of, Australia, Canada, Germany, Singapore
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer | Solid Tumor | Shared Neoantigen-Positive Solid TumorsUnited States
-
Novartis PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Oxford BioTherapeutics LtdRecruitingSolid TumorUnited States, Belgium, Spain, France, Greece
-
Chinook Therapeutics, Inc. (formerly Aduro)Novartis PharmaceuticalsTerminatedAdvanced/Metastatic Solid Tumors or LymphomasUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompleted
-
New Mexico Cancer Care AllianceTerminatedLiver CancerUnited States
-
Hoffmann-La RocheCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | NF1 Mutation Positive Malignant Peripheral Nerve Sheath TumorUnited States
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Innate PharmaAstraZenecaTerminatedAdvanced Solid TumorsUnited States, France
-
CelgeneCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Neurotoxicity | Radiation Toxicity | Cognitive/Functional EffectsUnited States
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierRecruitingMTAP-deleted Solid TumorsAustralia, United States
-
Stanford UniversityAmgen; Pediatric Oncology Experimental Therapeutics Investigators' ConsortiumCompletedRefractory Leukemia | Refractory Solid Tumors | Relapsed Solid Tumors | Relapsed LeukemiaUnited States, Canada
-
AstraZenecaCompletedSolid TumorsUnited States, France
-
Hoffmann-La RocheCompletedSolid TumorsHungary, United States, Korea, Republic of, Belgium, Germany, United Kingdom
-
Astellas Pharma IncRecruitingSolid TumorUnited States, Japan, France
-
The Cooper Health SystemCompletedCancer | Metastatic CancerUnited States
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Canada
-
Laminar PharmaceuticalsDana-Farber Cancer Institute; Hackensack Meridian Health; Laminar Pharma IncRecruitingHigh-grade Glioma | Solid Tumor, Unspecified, ChildUnited States
-
MedImmune LLCCompleted
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Gary MorrowNational Cancer Institute (NCI)CompletedFatigue | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
University of PittsburghNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Psychosocial Effects of Cancer and Its TreatmentUnited States
-
Memorial Sloan Kettering Cancer CenterPfizer; University of Wisconsin, Madison; Duke University; AEterna Zentaris; NATL...CompletedPediatric Solid TumorsUnited States